CCR Ostrava s.r.o.

Ostrava, Moravian-Silesian Region 702 00

0 studies enrolling now · 4 studies all time

What they study most

Migraine, Plaque Psoriasis

Studies at this site

• A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis — Running, not enrolling
• A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis — Completed
• A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period — Completed
• A Study With Lu AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments — Completed